1-(2,3,4-Trimethoxybenzyl)piperazine · 2 HCl
5011-34-7 (net), 13171-25-0 (dihydrochloride)
Trimetazidine is an anti-ischemic (anti-anginal) metabolic agent, which improves myocardial glucose utilization through inhibition of fatty acid metabolism, also known as fatty acid oxidation inhibitor.
Trimetazidine Dihydrochloride is a 3-ketoacyl-coenzyme, a thiolase inhibitor. It is a cellular antiischemic agent indicated in the management and prophylaxis of angina pectoris.
Areas of Interest
Ischemic heart disease & Chorioretinal vascular disorders